EcoDrugPlus

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSCSEG00000011796
Gene Symbol: ERBB4
3 Cross references
222 Possible Orthologues:

Estrogen Receptor

Ensembl ID : ENSCSEG00000017740
Gene Symbol: LOC103380669
3 Cross references
215 Possible Orthologues:

Estrogen Receptor Beta

Ensembl ID : ENSCSEG00000012785
Gene Symbol: LOC103382676
3 Cross references
207 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSCSEG00000003503
Gene Symbol: LOC103381193
3 Cross references
200 Possible Orthologues:

Estrogen-Related Receptor Gamma A

Ensembl ID : ENSCSEG00000008474
Gene Symbol: ESRRGA
1 Cross references
203 Possible Orthologues:

Exportin 1

Ensembl ID : ENSCSEG00000001693
Gene Symbol: XPO1
3 Cross references
217 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSCSEG00000002370
Gene Symbol: FDPS
3 Cross references
269 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSCSEG00000020538
Gene Symbol: FDFT1
3 Cross references
221 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSCSEG00000016931
Gene Symbol: FNTA
3 Cross references
222 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSCSEG00000001694
Gene Symbol: FGFR1
1 Cross references
196 Possible Orthologues:

Fibroblast Growth Factor Receptor 1a

Ensembl ID : ENSCSEG00000016296
Gene Symbol: FGFR1A
1 Cross references
209 Possible Orthologues:

Fibroblast Growth Factor Receptor 2-Like

Ensembl ID : ENSCSEG00000017754
Gene Symbol: LOC103391367
3 Cross references
214 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).